ELAPRASE
- Product NDC
- 54092-700
- 11-digit product format
- 540920700
- Labeler code
- 54092
- Product ID
- 54092-700_25f45811-e646-4342-9954-d8220cadf886
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- idursulfase
- Dosage form
- SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Application
- BLA125151
- Marketing category
- BLA
- Marketing start
- 2006-07-24
- Substance
- IDURSULFASE
- Active strength
- 6 mg/3mL
- Pharmacologic classes
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ELAPRASE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IDURSULFASE | 6 mg/3mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5W8JGG2651 |
| Rxcui | 644104, 647118 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 54092-700-01 | ELAPRASE | 1 in 1 BOX | SOLUTION, CONCENTRATE | 1 | | 25 |
| 54092-700-01 | ELAPRASE | 3 mL in 1 VIAL, GLASS | SOLUTION, CONCENTRATE | 3 | | 25 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| idursulfase | ACTIVE INGREDIENT | 5W8JGG2651 | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| idursulfase | ACTIVE MOIETY | 5W8JGG2651 | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| sodium phosphate, dibasic, heptahydrate | INACTIVE INGREDIENT | 70WT22SF4B | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 54092-700 | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 25 | Current NDC, Legacy NDC, 2 package rows | 20250418_60cba843-5aab-4dd7-96dc-66648d413be3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 54092-700-01 | 54092070001 | 1 VIAL, GLASS in 1 BOX (54092-700-01) / 3 mL in 1 VIAL, GLASS | 2006-07-24 | 0000-00-00 | No | No | Current |